Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  H. Lundbeck A/S    LUN   DK0010287234

H. LUNDBECK A/S

(LUN)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
193.15(c) 189.9(c) 191.75(c) 191.9(c) 193.95(c) Last
325 665 365 136 257 132 139 779 366 779 Volume
-0.92% -1.68% +0.97% +0.08% +1.07% Change
More quotes
Financials
Sales 2020 17 783 M 2 860 M 2 860 M
Net income 2020 1 378 M 222 M 222 M
Net Debt 2020 3 712 M 597 M 597 M
P/E ratio 2020 27,2x
Yield 2020 1,50%
Sales 2021 17 452 M 2 807 M 2 807 M
Net income 2021 1 937 M 312 M 312 M
Net Debt 2021 1 921 M 309 M 309 M
P/E ratio 2021 19,7x
Yield 2021 1,99%
Capitalization 38 540 M 6 193 M 6 198 M
EV / Sales 2020 2,38x
EV / Sales 2021 2,32x
Nbr of Employees 5 761
Free-Float 30,8%
More Financials
Company
H. Lundbeck A/S specializes in the development, production and marketing of medicines for the treatment of psychiatric and neurological disorders (depression, schizophrenia, Lennox-Gastaut syndrome, Parkinson's disease, Huntington's disease, epilepsy, sleep disorders, etc.). 
Sector
Pharmaceuticals
Calendar
02/04Earnings Release
More about the company
All news about H. LUNDBECK A/S
11/27H LUNDBECK A/S : The Danish Business Authority ("Erhvervsstyrelsen") requires Lu..
AQ
11/03H LUNDBECK A/S : Solid performance across strategic brands with 19% growth in th..
AQ
11/03H. LUNDBECK A/S : 3rd quarter results
CO
10/09H LUNDBECK A/S : Lundbeck successfully places its first EUR 500 million Eurobond..
AQ
10/08H LUNDBECK A/S : Lundbeck successfully places its first EUR 500 million Eurobond..
AQ
09/18H LUNDBECK A/S : Lundbeck presents positive data from the COMPLETE study with vo..
AQ
09/17H LUNDBECK A/S : Lundbeck presents positive data from the COMPLETE study with vo..
AQ
09/01H. LUNDBECK A/S : - Positive headline results from the Vyepti RELIEF study
AQ
08/13H LUNDBECK A/S : Strong momentum across all strategic brands with 25% growth in ..
AQ
08/13H. LUNDBECK A/S : Half-year results
CO
08/05H LUNDBECK A/S : Lundbeck discontinues phase II proof of concept study of Lu AF1..
AQ
06/09H LUNDBECK A/S : Lundbeck plans to refocus and reinvigorate Research & Developme..
AQ
06/04Setback for Lundbeck as EU court adviser backs EU antitrust fine
RE
05/13H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
AQ
05/12Lundbeck boosted by stockpiling, launches key drug remotely
RE
More news
News in other languages on H. LUNDBECK A/S
11/04Coucou, me revoilou ?
11/04AVIS D'ANALYSTES DU JOUR : Adecco, BNP Paribas, Carrefour, Lundbeck, Qiagen, Sch..
09/25TOUR DU MONDE DES INDICES :  Tesla-dépendance et irréductibles danois
08/28Quand les poules auront des dents !
08/28AVIS D'ANALYSTES DU JOUR : Accor, Ahold Delhaize, Alstom, Cassiopea, Eiffage, Sa..
More news
Analyst Recommendations on H. LUNDBECK A/S
More recommendations
Chart H. LUNDBECK A/S
Duration : Period :
H. Lundbeck A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends H. LUNDBECK A/S
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 226,21 DKK
Last Close Price 193,95 DKK
Spread / Highest target 72,7%
Spread / Average Target 16,6%
Spread / Lowest Target -12,3%
EPS Revisions
Managers
NameTitle
Deborah L. Dunsire President & Chief Executive Officer
Lars Sřren Rasmussen Chairman
Anders Götzsche Chief Financial Officer, Director & Executive VP
Lars Bang Executive VP-Supply Operations & Engineering
Johan Luthman EVP & Head-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
H. LUNDBECK A/S-23.76%6 193
DAIICHI SANKYO COMPANY, LIMITED56.60%72 682
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 850
YUNNAN BAIYAO GROUP CO.,LTD7.23%18 673
ORION OYJ-3.10%6 712
SWEDISH ORPHAN BIOVITRUM AB1.42%5 440